BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 2443573)

  • 1. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
    Antes U; Heinz HP; Loos M
    Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.
    Antes U; Heinz HP; Schultz D; Brackertz D; Loos M
    Rheumatol Int; 1991; 10(6):245-50. PubMed ID: 2041983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases.
    Wener MH; Uwatoko S; Mannik M
    Arthritis Rheum; 1989 May; 32(5):544-51. PubMed ID: 2785797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of circulating immune complexes containing C1q and IgG using a new rapid serum ELISA test system.
    Reckel RP; Harris J; Botsko E; Wellerson R; Varga S
    Diagn Immunol; 1984; 2(4):228-37. PubMed ID: 6335421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia.
    Agnello V; Mitamura T
    Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC; Bey RF; Loken KI
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q and immune complexes in liver cirrhosis sera.
    Yoshida H; Sato M; Watanabe S; Nishimaki T; Morito T; Kasukawa R; Nakai M
    Tohoku J Exp Med; 1983 May; 140(1):73-9. PubMed ID: 6603034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assay for C1q in human serum by use of monoclonal antibodies.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1984 Nov; 74(2):299-306. PubMed ID: 6209338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
    Greisman SG; Redecha PB; Kimberly RP; Christian CL
    J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities.
    Mårtensson U; Sjöholm AG; Sturfelt G; Truedsson L; Laurell AB
    Scand J Immunol; 1992 Jun; 35(6):735-44. PubMed ID: 1604245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
    Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
    Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    Clin Immunol Immunopathol; 1984 Jan; 30(1):104-16. PubMed ID: 6421520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
    Larsson A; Jonsson L; Sjöquist J
    J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus.
    Wener MH; Mannik M; Schwartz MM; Lewis EJ
    Medicine (Baltimore); 1987 Mar; 66(2):85-97. PubMed ID: 3102894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1q solid-phase radioimmunoassay: binding properties of solid-phase C1q and evidence that C1q-binding IgG complexes in systemic lupus erythematosus are not bound to endogenous C1q.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    J Immunol Methods; 1984 Oct; 73(1):67-74. PubMed ID: 6436382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.